In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
News|Articles|September 15, 2017
Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
Advertisement
People News
Elligo Health Research, a clinical research infrastructure provider of clinical research infrastructure (CRI) services and technologies, has hired Deirdre BeVard as chief operating officer.
Clinipace Worldwide, a global full-service CRO, has named industry veteran Steve Skolsky to its Board of Directors. Steve holds 30 years of experience in the pharma, biotech, CRO, and health care services sectors.
Karolinska Development's portfolio company Modus Therapeutics AB, a Nordic life sciences investment company, has recruited Professor Thomas Knittel as its new Chief Medical Officer. Thomas brings along 10 years of clinical and over 15 years of experience from research and development, medical affairs, and marketing within the pharmaceutical industry.
Business News
Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of apps that helps biotech and pharma sponsors transform the way data is captured, monitored, and reviewed in clinical trials.
OmniComm Systems, Inc., a global provider of clinical data management technology, announced that it has received certification approval from the U.S. Department of Commerce for the EU-U.S. Privacy Shield Framework program and the Swiss-U.S. Privacy Shield Framework, the successors to the U.S.-EU and U.S.-Swiss Safe Harbor Frameworks.
Clintec, a global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the
category of International Trade, the highest business accolade that can be granted to any business operating within the UK.
Forte, an industry developer of clinical research solutions, announced the launch of its new brand identity and redesigned website, ForteResearch.com. The new website launch represents their vision for the future as a company.
Certara, a global company in model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. They are the 36th biopharmaceutical and 11th Japanese pharmaceutical company to join the Consortium.
Advertisement
Related to this article
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
5